A new survey of 155 Lyme doctors who treat patients with persistent and chronic Lyme disease reveals the significant challenges to providing patient care that is local, timely, and affordable, published in the journal, Healthcare.
Analysis shows that a primary barrier to affordable care is an insurance reimbursement system that doesn’t acknowledge the time and real costs associated with treating complex, chronic diseases. A secondary barrier is the professional stigma associated with treating chronic Lyme disease, a disease where persistent symptoms are often dismissed as “all in the head” and where the use of long-term antibiotics—even when necessary—are demonized by the medical system. Many Lyme-treating physicians are subjected to investigations by state medical boards, insurers, and hospital committees, pressures that result in physicians leaving this specialty. A shocking three-quarters of the physician-respondents have been treated disrespectfully by professional colleagues because they treat Lyme patients.
Authors Lorraine Johnson, JD, MBA, of MyLymeData, and Elizabeth Maloney, MD, Invisible International’s Education Co-director, both veterans at exploring solutions to the Lyme disease problem, explain the impact on patients here:
“Because the traditional economic model of medical provider compensation relies heavily on insurance coverage and working in-network, when clinicians opt out of the insurance model, it shifts the economic burden of care to patients.”
|